Literature DB >> 12114642

The Immunophenotype of Pituitary Adenomas.

Ricardo V. Lloyd1, Bernd W. Scheithauer, Kalman Kovacs, Patrick C. Roche.   

Abstract

Although the production of pituitary hormones by adenohypophysial tumors has been studied extensively, an examination of the immunophenotype of pituitary adenomas using a broad spectrum of antibodies has not been previously investigated. We studied 23 pituitary adenomas using a large panel of antibodies to determine if these tumors exhibited a common immunophenotype. Various neuroendocrine markers, synaptophysin, neuron-specific enolase (NSE), and the intermediate filament protein, low-mol-wt keratin were expressed in most examples. There was, however, differential expression of chromogranin A in that few prolactin (PRL) and adenocorticotrophic hormone (ACTH) adenomas stained positively, whereas all other adenoma subtypes were reactive. The ACTH adenomas had a unique profile with positive staining for galanin, neurophysiri, vasopressin, and ubiquitin. These results indicate that (1) pituitary adenomas do not express a single "generic" immunophenotype; (2) synaptophysin is the most reliable and best broad spectrum marker for pituitary adenomas; (3) the neuroendocrine granule marker chromogranin A is useful in the identification of null cell adenoma, a tumor that usually does not stain for anterior pituitary tumors; and (4) among pituitary tumors, ACTH adenomas have a unique immunoprofile.

Entities:  

Year:  1996        PMID: 12114642     DOI: 10.1007/bf02739974

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  13 in total

1.  Evidence of gonadotropin-releasing hormone mRNA in the rat anterior pituitary.

Authors:  P Pagesy; J Y Li; M Berthet; F Peillon
Journal:  Mol Endocrinol       Date:  1992-04

2.  Presence of neurophysins in the human pituitary corticotrophs, Cushing's adenomas, and growth hormone-producing adenomas detected by immunohistochemical study.

Authors:  N Kimura; N Andoh; N Sasano; A Sasaki; T Mouri
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

3.  Anti-lymphocyte antibody Leu-7 (HNK-1) recognizes a constituent of neuroendocrine granule matrix.

Authors:  A S Tischler; H Mobtaker; K Mann; G Nunnemacher; W J Jason; Y Dayal; R A Delellis; L Adelman; H J Wolfe
Journal:  J Histochem Cytochem       Date:  1986-09       Impact factor: 2.479

4.  Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.

Authors:  D W Hsu; P N Riskind; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Presence of galanin-like immunoreactivity in nontumorous corticotrophs and corticotroph adenomas of the human pituitary.

Authors:  M E Vrontakis; T Sano; K Kovacs; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1990-03       Impact factor: 5.958

7.  Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas.

Authors:  R V Lloyd; B S Wilson; K Kovacs; N Ryan
Journal:  Arch Pathol Lab Med       Date:  1985-06       Impact factor: 5.534

8.  Null cell adenoma of the human pituitary.

Authors:  K Kovacs; E Horvath; N Ryan; C Ezrin
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

9.  Immunocytochemical localization of synaptophysin in human hypophyses and pituitary adenomas.

Authors:  L Stefaneanu; N Ryan; K Kovacs
Journal:  Arch Pathol Lab Med       Date:  1988-08       Impact factor: 5.534

10.  Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.

Authors:  S L Asa; N Ryan; K Kovacs; W Singer; P J Marangos
Journal:  Arch Pathol Lab Med       Date:  1984-01       Impact factor: 5.534

View more
  9 in total

1.  Cytokeratin CK 7 and CK 20 expression in pituitary adenomas.

Authors:  Stephen W Coons; Sarah I Estrada; Ruben Gamez; William L White
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas.

Authors:  K H Ruebel; L Jin; S Zhang; B W Scheithauer; R V Lloyd
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Cushing's disease arising from a clinically nonfunctioning pituitary adenoma.

Authors:  Luiz Roberto Salgado; Márcio Carlos Machado; Arthur Cukiert; Bernardo Liberman; Cristina Takami Kanamura; Venancio Avancini Ferreira Alves
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 4.  Best Practice No 172: pituitary gland pathology.

Authors:  J W Ironside
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

5.  Hormone markers in pituitary adenomas: changes within last decade resulting from improved method.

Authors:  Wolfgang Saeger; Waldemar Wilczak; Dieter K Lüdecke; Michael Buchfelder; Rudolf Fahlbusch
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

6.  Vascular Endothelial Growth Factor (VEGF) Expression in Human Pituitary Adenomas and Carcinomas.

Authors:  Ricardo V. Lloyd; Bernd W. Scheithauer; Takao Kuroki; Sergio Vidal; Kalman Kovacs; Lucia Stefaneanu
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

7.  Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease.

Authors:  Kazumi Iino; Yutaka Oki; Fumie Matsushita; Miho Yamashita; Chiga Hayashi; Katsutoshi Miura; Shigeru Nishizawa; Hirotoshi Nakamura
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

8.  MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma.

Authors:  Michael B Miller; Wenya Linda Bi; Lori A Ramkissoon; Yun Jee Kang; Malak Abedalthagafi; David S Knoff; Pankaj K Agarwalla; Patrick Y Wen; David A Reardon; Brian M Alexander; Edward R Laws; Ian F Dunn; Rameen Beroukhim; Keith L Ligon; Shakti H Ramkissoon
Journal:  Oncotarget       Date:  2016-06-14

Review 9.  Pituitary Gangliocytoma Producing TSH and TRH: A Review of "Gangliocytomas of the Sellar Region".

Authors:  Kiyohiko Sakata; Kana Fujimori; Satoru Komaki; Takuya Furuta; Yasuo Sugita; Kenji Ashida; Masatoshi Nomura; Motohiro Morioka
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.